Uniphar PLC
334.00
GBX
0.00
(0.00%)
ISIN
IE00BJ5FQX74
Return %
Stock
S&P 500
1Y
-0.30
14.20
3Y
73.51
81.12
5Y
-7.22
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Gerard Rabbette
- Full Time Employees
- 3,500
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- 4045 Kingswood Road Dublin DU Ireland D24 V06K
- IPO Date
- Jul 17, 2019
- Website
- uniphar.ie
- Similar Companies
- Business
- Uniphar plc operates as a diversified healthcare services provider focused on pharmaceutical distribution, medical devices, and specialized pharma support services. The company, founded in 1967 and headquartered in Dublin, Ireland, delivers its offerings through three primary divisions: Uniphar Medtech, which provides sales, marketing, compliance, and distribution services to medical device manufacturers across specialties including interventional cardiology, radiology, orthopaedics, ophthalmology, minimally invasive surgery, diagnostic imaging, and critical care; Uniphar Pharma, which supplies high-value services across the pharmaceutical product lifecycle such as global sourcing of unlicensed and hard-to-access medicines, managed access programs, medical affairs, clinical development, and product fostering for over 200 multinational pharma and biotech clients in more than 160 countries; and Uniphar Supply Chain & Retail, which handles pre-wholesale and wholesale distribution of pharmaceuticals, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons, alongside operating a network of retail pharmacies under the Life, Allcare, Hickey’s, and McCauley brands. Uniphar serves public and private sector customers primarily in Ireland, the United Kingdom, the Netherlands, the United States, Europe, APAC, and MENA regions, with approximately 3,500 employees and annual revenue exceeding €2 billion. Recent developments include a major U.S. expansion announced in November 2025, integrating RRD BioPharma Development, Uniphar Clinical, Diligent Health Solutions, and BESTMSLs under the Uniphar brand, complemented by the opening of a new 65,000 sq. ft. GMP- and GDP-compliant facility in Raleigh, North Carolina; the acquisition of Inspired Health, Inc. from West Monroe Partners in December 2024 with integration set for the first half of 2025; a strategic partnership with Secura Bio for global Managed Access Programs covering products like Farydak and Copiktra; and a rebranding of its On Demand business to Uniphar Global Sourcing in July 2025 to bolster its pharmaceutical offerings.